REDV (TFA)
REDV TFA is the minimal active sequence within the CS5 site of the alternatively spliced type III connecting segment (IIICS) region of fibronectin. REDV TFA can mediate adhesion to the IIICS region of plasma fibronectin by binding the integrin alpha 4 beta 1 (α4β1) . REDV TFA can be used for the research of cell adhesion[1].
Product Specifications
UNSPSC
12352209
Target
Integrin
Type
Peptides
Related Pathways
Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/redv-tfa.html
Purity
99.81
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(O)=O)=O)=O)[C@H](CCCNC(N)=N)N.O=C(O)C(F)(F)F.[x]
Molecular Formula
C20H35N7O9.xC2HF3O2
Molecular Weight
517.53 (free acid)
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Bcl-x (BX006 + 2H12), CF405S conjugate, 0.1mg/mL
TAS1R3 Human Recombinant Protein, Synthetic Nanodisc
Cytokeratin 19 (KRT19/799 + KRT19/800), Biotin conjugate, 0.1mg/mL
